James C. Gale is Director at INDEVUS PHARMACEUTICALS INC (IDEV). They have made 19 open-market trades across 5 companies since 2004, most recently 2019-05-31.
CIK 0001184312
7 open-market purchases totalling $352K since 2013, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TLGT | BUY | 2019-05-31 | 2019-05-31 | $0.66 | $13K | -19.0% | -4.4% | +16.2% |
| TLGT | BUY | 2019-05-23 | 2019-05-24 | $0.69 | $14K | -10.4% | -23.5% | -5.4% |
| TLGT | BUY | 2017-11-10 | 2017-11-13 | $3.81 | $57K | +9.1% | +10.2% | -15.0% |
| TLGT | BUY | 2016-03-11 | 2016-03-14 | $4.91 | $74K | -9.1% | +0.4% | +19.9% |
| IG | BUY | 2015-04-30 | 2015-05-01 | $5.04 | $151K | N/A | N/A | N/A |
| PFNX | SELL | 2015-04-29 | 2015-04-30 | $14.57 | $27.8M | -24.9% | -3.6% | -3.6% |
| IG | SELL | 2014-08-27 | 2014-08-29 | $6.20 | $18.6M | N/A | N/A | N/A |
| IG | BUY | 2014-08-22 | 2014-08-26 | $5.90 | $30K | N/A | N/A | N/A |
| PFNX | SELL | 2014-07-29 | 2014-07-31 | $0.31 | $118K | -24.9% | -3.6% | -3.6% |
| IG | BUY | 2013-03-13 | 2013-03-15 | $1.33 | $13K | N/A | N/A | N/A |
| IDEV | SELL | 2007-10-18 | 2007-10-23 | $7.90 | $19.8M | N/A | N/A | N/A |
| IDEV | SELL | 2007-06-14 | 2007-06-18 | $7.30 | $929K | N/A | N/A | N/A |
| IDEV | SELL | 2007-06-07 | 2007-06-11 | $7.35 | $1.5M | N/A | N/A | N/A |
| IDEV | SELL | 2007-06-05 | 2007-06-07 | $7.35 | $2.5M | N/A | N/A | N/A |
| IDEV | SELL | 2007-06-01 | 2007-06-06 | $7.38 | $2.2M | N/A | N/A | N/A |
| IDEV | SELL | 2007-05-30 | 2007-06-01 | $7.37 | $1.6M | N/A | N/A | N/A |
| IDEV | SELL | 2007-05-25 | 2007-05-30 | $7.32 | $1.9M | N/A | N/A | N/A |
| IDEV | SELL | 2007-05-21 | 2007-05-29 | $7.36 | $1.9M | N/A | N/A | N/A |
| RWC | SELL | 2004-05-25 | 2006-01-17 | $2.77 | $360K | -2.8% | +1.1% | +1.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.